Beside C-MYC rearrangements, expression of C-MYC protein > 40% together with BCL2 expression in > 50% of lymphoma cells has been reported to be associated with a poor outcome which is however better than in HGBL, C-MYC. This evidence concerns the gene MYC and lymphoma.